GTHCX: Invesco Health Care Fund - MutualFunds.com
Continue to site >
Trending ETFs

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.
Not interested

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Invesco Health Care C

GTHCX - Snapshot

Vitals

  • YTD Return 3.7%
  • 3 Yr Annualized Return 14.1%
  • 5 Yr Annualized Return 8.3%
  • Net Assets $1.62 B
  • Holdings in Top 10 37.5%

52 WEEK LOW AND HIGH

$28.67
$19.58
$30.34

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.81%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 11.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000
  • IRA $250

Fund Classification

Compare GTHCX to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Vanguard Health Care Fund

Fund

$225.05

+0.83%

$49.03 B

0.84%

$1.89

4.33%

-

Health Care Select Sector SPDR® Fund

XLV | ETF

$118.50

+0.55%

$25.69 B

1.43%

$1.69

4.46%

-

T. Rowe Price Health Sciences Fund

Fund

$105.56

+1.32%

$17.43 B

-

$0.00

6.79%

-

Vanguard Health Care Index Fund

Fund

$117.33

+0.90%

$15.36 B

1.17%

$1.36

4.84%

-

Vanguard Health Care Index Fund

VHT | ETF

$235.68

+0.43%

$15.36 B

1.16%

$2.71

5.34%

-

GTHCX - Profile

Distributions

  • YTD Total Return 3.7%
  • 3 Yr Annualized Total Return 14.1%
  • 5 Yr Annualized Total Return 8.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.67%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Invesco Health Care Fund
  • Fund Family Name
    Invesco
  • Inception Date
    Mar 01, 1999
  • Shares Outstanding
    N/A
  • Share Class
    C
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Henry Wu

Fund Description

The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities. It invests primarily in equity securities, securities convertible into equity securities, and depositary receipts. The fund may invest in the securities of issuers of all capitalization sizes and may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.

GTHCX - Performance

Return Ranking - Trailing

Period GTHCX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.7% 1.3% 20.6% 81.98%
1 Yr 13.6% 3.0% 180.5% 82.21%
3 Yr 14.1%* 3.8% 59.5% 63.64%
5 Yr 8.3%* 1.0% 36.9% 75.00%
10 Yr 12.3%* 9.8% 21.3% 92.68%

* Annualized

Return Ranking - Calendar

Period GTHCX Return Category Return Low Category Return High Rank in Category (%)
2020 2.7% -13.6% 178.2% 90.06%
2019 24.5% 3.8% 63.8% 26.90%
2018 -11.5% -49.7% 21.5% 77.37%
2017 4.3% -59.8% 54.4% 89.63%
2016 -15.0% -36.6% 11.6% 51.16%

Total Return Ranking - Trailing

Period GTHCX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.7% 1.3% 20.0% 80.23%
1 Yr 12.6% -2.3% 180.5% 83.44%
3 Yr 14.1%* 2.4% 59.5% 60.84%
5 Yr 8.3%* 1.0% 36.9% 70.71%
10 Yr 12.3%* 9.8% 21.3% 92.68%

* Annualized

Total Return Ranking - Calendar

Period GTHCX Return Category Return Low Category Return High Rank in Category (%)
2020 2.7% -13.6% 178.2% 90.06%
2019 24.5% 3.8% 63.8% 26.90%
2018 -11.5% -25.3% 22.2% 78.83%
2017 14.6% -10.8% 54.4% 73.33%
2016 -12.3% -36.6% 11.6% 47.29%

NAV & Total Return History

GTHCX - Holdings

Concentration Analysis

GTHCX Category Low Category High GTHCX % Rank
Net Assets 1.62 B 6.3 M 49 B 34.88%
Number of Holdings 97 24 452 47.67%
Net Assets in Top 10 556 M 1.2 M 19.6 B 42.44%
Weighting of Top 10 37.53% 8.8% 76.9% 58.14%

Top 10 Holdings

  1. Thermo Fisher Scientific Inc 5.92%
  2. UnitedHealth Group Inc 4.83%
  3. Johnson & Johnson 4.11%
  4. AstraZeneca PLC ADR 4.09%
  5. Novartis AG ADR 3.93%
  6. Medtronic PLC 3.79%
  7. Abbott Laboratories 3.03%
  8. Eli Lilly and Co 2.62%
  9. Vertex Pharmaceuticals Inc 2.60%
  10. Sanofi SA ADR 2.60%

Asset Allocation

Weighting Return Low Return High GTHCX % Rank
Stocks 		97.03% 77.04% 104.32% 73.26%
Cash 		2.97% -0.10% 12.53% 13.37%
Preferred Stocks 		0.00% 0.00% 5.23% 16.86%
Other 		0.00% -27.80% 10.43% 31.40%
Convertible Bonds 		0.00% 0.00% 0.06% 5.81%
Bonds 		0.00% 0.00% 19.34% 12.79%

Stock Sector Breakdown

Weighting Return Low Return High GTHCX % Rank
Healthcare 		99.70% 61.64% 100.00% 47.09%
Consumer Defense 		0.30% 0.00% 33.59% 2.33%
Utilities 		0.00% 0.00% 0.03% 5.81%
Technology 		0.00% 0.00% 15.86% 19.19%
Real Estate 		0.00% 0.00% 5.95% 11.63%
Industrials 		0.00% 0.00% 5.94% 16.28%
Financial Services 		0.00% 0.00% 4.10% 39.53%
Energy 		0.00% 0.00% 0.03% 6.40%
Communication Services 		0.00% 0.00% 4.69% 9.30%
Consumer Cyclical 		0.00% 0.00% 1.19% 15.12%
Basic Materials 		0.00% 0.00% 3.30% 34.30%

Stock Geographic Breakdown

Weighting Return Low Return High GTHCX % Rank
US 		75.74% 56.44% 100.00% 69.77%
Non US 		21.29% 0.00% 41.69% 19.19%

GTHCX - Expenses

Operational Fees

GTHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.81% 0.08% 25.14% 23.35%
Management Fee 0.63% 0.00% 1.25% 45.35%
12b-1 Fee 1.00% 0.00% 1.00% 73.33%
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

GTHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load 1.00% 1.00% 5.00% 14.29%

Trading Fees

GTHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

GTHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 11.00% 0.70% 252.00% 7.93%

GTHCX - Distributions

Dividend Yield Analysis

GTHCX Category Low Category High GTHCX % Rank
Dividend Yield 0.00% 0.00% 1.03% 19.19%

Dividend Distribution Analysis

GTHCX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

GTHCX Category Low Category High GTHCX % Rank
Net Income Ratio -0.67% -2.53% 1.74% 86.90%

Capital Gain Distribution Analysis

GTHCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

GTHCX - Fund Manager Analysis

Managers

Henry Wu

Start Date

Tenure

Tenure Rank

Feb 28, 2017

3.84

3.8%

Henry Wu, Portfolio Manager, has been associated with Invesco and/or its affiliates since 2014 (and was previously associated with Invesco and/or its affiliates from 2006 to 2010). From 2012 to 2013, he was employed by Scopia Capital as a senior analyst. From 2010 to 2012, he was employed by Surveyor Capital/Citdadel Investment Group as an analyst.

Justin Livengood

Start Date

Tenure

Tenure Rank

Dec 18, 2020

0.04

0.0%

Mr. Livengood has been a Vice President of OppenheimerFunds since May 2006 and a Senior Portfolio Manager since January 2014. He was a Senior Research Analyst from May 2006 to January 2014, responsible for the health care, energy and financial services sectors for mid- and small-cap growth accounts. Before joining OppenheimerFunds in May 2006, Mr. Livengood was a vice president and fund analyst with Merrill Lynch Investment Managers. During his tenure at Merrill Lynch he also worked as an investment banking analyst in the Global Media Group and as an associate with Merrill Lynch Ventures.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.04 23.31 7.3 20.68

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.